Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study

Arthritis & Rheumatism

Volumn 34, Issue 8, 1991, Pages 937-944

  Petri, Michelle ^a,b   Genovese, Mark ^a,b   Engle, Eric ^a,b   Hochberg, Marc ^a,b  

^a Department of Medicine ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLASSIFICATION; DIAGNOSIS; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; COHORT STUDIES; FEMALE; HUMAN; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025900754     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780340802     Document Type: Article

References (20)

1. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population
2. Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively
3. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively
4. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus
5. Prognosis in SLE: comparison of Markov model to life table analysis
6. Measurement of systemic lupus erythematosus activity in clinical research
7. Towards an operational definition of SLE activity for clinical research
8. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
9. Fatal infections in systemic lupus erythematosus: role of opportunistic organisms
10. Accuracy of creatinine clearance in measuring glomerular filtration rate in patients with systemic lupus erythematosus without clinical evidence of renal disease
11. Serial assessment of glomerular filtration rate in lupus nephropathy
12. Validity and reliability of the Lupus Activity Index (LAI): comparison with the Toronto Activity Index (SLEDAI) and Systemic Lupus Activity Measure (SLAM) (abstract)
13. Prognosis studies in SLE: an activity index (abstract)
14. International validation of three disease activity measures in systemic lupus erythematosus
15. A comparison of disease activity scores in SLE (abstract)
16. The 1982 revised criteria for the classification of systemic lupus erythematosus
17. Prognostic value of anti‐dsDNA in SLE
18. Measurement of increases in anti–double‐stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long‐term, prospective study